坎地沙坦和多种炎性标记物在房颤电复律后窦性心律维持中的作用

• 作 者: Tveit A. Seljeflot I. Grundvold I. 王海玲
• 机 构: Department of Internal Medicine Asker and Baerum Hospital Rud Norway,
• 出 处: 世界核心医学期刊文摘(心脏病学分册)
• 发表日期: 2007年09期
• 关键词: 电复律 窦性心律维持 坎地沙坦 标记物 选择素 窦性心律 安慰剂对照 双盲 持续性 后窦性心律

该项双盲、安慰剂对照研究(CAPRAF研究)探讨了炎性标记物与房颤(AF)电复律后窦性心律维持的关系,以及坎地沙坦在其中的作用。将171例持续性AF患者随机分为2组:试验组在电复律前服用坎地沙

This double-blind, placebo-controlled study (CAPRAF study) explores the relationship between inflammatory markers and maintenance of sinus rhythm after electrical cardioversion of AF and the role of candesartan in this. 171 patients with persistent AF were randomly divided into two groups: the test group was given candesartan before electrical cardioversion